Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Fukuda, Takahiro  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Ishiyama, K., Yamaguchi, T., Eto, T., Ohashi, K., Uchida, N., Kanamori, H., Fukuda, T., Miyamura, K., Inoue, Y., Taguchi, J., et al. (2016). Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT.Leuk Res47, 47-53.
Akahoshi, Y., Mizuta, S., Shimizu, H., Uchida, N., Fukuda, T., Kanamori, H., Onizuka, M., Ozawa, Y., Ohashi, K., Ohta, S., et al. (2018). Additional cytogenetic abnormalities with Philadelphia chromosome-positive acute lymphoblastic leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era.Biol Blood Marrow Transplant.
Kondo, E., Shimizu-Koresawa, R., Chihara, D., Mizuta, S., Izutsu, K., Ikegame, K., Uchida, N., Fukuda, T., Ichinohe, T., Atsuta, Y., et al. (2019). Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantatio.Br J Haematol.
Itonaga, H., Ota, S., Ikeda, T., Taji, H., Amano, I., Hasegawa, Y., Ichinohe, T., Fukuda, T., Atsuta, Y., Tanizawa, A., et al. (2018). Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.Leuk Res75, 50-57.
Ogata, M., Phan, T., and Fukuda, T. (2018). Antiviral Therapy for the Treatment of HHV-6-Associated Syndromes after Transplantation.Am J Transplant.
Kawajiri, A., Kitano, S., Maeshima, A.Miyagi, Inamoto, Y., Tajima, K., Takemura, T., Tanaka, T., Ito, A., Okinaka, K., Kurosawa, S., et al. (2019). Association of CD204 macrophages with poor outcomes of malignant lymphomas not in remission treated by allo-HCT.Eur J Haematol.
C
Ito, R., Inamoto, Y., Inoue, Y., Ito, A., Tanaka, T., Fuji, S., Okinaka, K., Kurosawa, S., Kim, S.-W., Yamashita, T., et al. (2018). Characterization of late acute and chronic graft-versus-host disease according to the 2014 NIH consensus criteria in Japanese patients.Biol Blood Marrow Transplant.
Inamoto, Y., Kimura, F., Kanda, J., Sugita, J., Ikegame, K., Nakasone, H., Nannya, Y., Uchida, N., Fukuda, T., Yoshioka, K., et al. (2016). Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.Haematologica.
Atsuta, Y., Kato, S., Morishima, Y., Ohashi, K., Fukuda, T., Ozawa, Y., Eto, T., Iwato, K., Uchida, N., Ota, S., et al. (2018). Comparison of HLA allele mismatch and antigen mismatch in unrelated bone marrow transplantation in patients with leukemia.Biol Blood Marrow Transplant.
Terakura, S., Atsuta, Y., Tsukada, N., Kobayashi, T., Tanaka, M., Kanda, J., Najima, Y., Fukuda, T., Uchida, N., Takahashi, S., et al. (2015). Comparison of outcomes of 8/8 and 7/8 allele-matched unrelated BMT and single unit CBT in adults with acute leukemia.Biol Blood Marrow Transplant.
Murata, M., Takenaka, K., Uchida, N., Ozawa, Y., Ohashi, K., Kim, S.-W., Ikegame, K., Kanda, Y., Kobayashi, H., Ishikawa, J., et al. (2019). Comparison of outcomes of allogeneic transplantation for primary myelofibrosis among hematopoietic stem cell source groups.Biol Blood Marrow Transplant.
Konuma, T., Kondo, T., Mizuno, S., Doki, N., Aoki, J., Fukuda, T., Tanaka, M., Sawa, M., Katayama, Y., Uchida, N., et al. (2019). Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission.Biol Blood Marrow Transplant.
Takano, K., Ogata, M., Satou, T., Miyazaki, Y., Otsuka, E., Saito, N., Ueki, T., Kako, S., Fukuda, T., and Shirao, K. (2019). Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV-6B encephalitis after hematopoietic stem cell transplantation.Transpl Infect Dise13172.
Kurosawa, S., Mori, A., Tsukagoshi, M., Onishi, Y., Ohwada, C., Mori, T., Goto, H., Asano-Mori, Y., Nawa, Y., Hino, M., et al. (2020). Current status and needs of long-term follow-up clinics for hematopoietic cell transplant survivors: results of a nationwide survey in Japan.Biol Blood Marrow Transplant.
E
Yamasaki, S., Nitta, H., Kondo, E., Uchida, N., Miyazaki, T., Ishiyama, K., Kiyota, M., Matsuoka, H., Ichinohe, T., Fukuda, T., et al. (2019). Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.Ann Hematol.
Murayama, T., Fukuda, T., Okumura, H., Sunami, K., Sawazaki, A., Maeda, Y., Tsurumi, H., Uike, N., Hidaka, T., Takatsuka, Y., et al. (2016). Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04.Int J Hematol.
Tanaka, T., Inamoto, Y., Yamashita, T., Fuji, S., Okinaka, K., Kurosawa, S., Kim, S.-W., Tanosaki, R., and Fukuda, T. (2016). Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant.
Hashimoto, H., Kitano, S., Ueda, R., Ito, A., Tada, K., Fuji, S., Kim, S.-W., Yamashita, T., Tomura, D., Nukaya, I., et al. (2015). Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.Int J Hematol.
Yuda, S., Fuji, S., Onishi, A., Tanaka, T., Inamoto, Y., Kurosawa, S., Kim, S.-W., and Fukuda, T. (2019). Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
H
Konuma, T., Kondo, T., Kawata, T., Iwato, K., Sato, Y., Mori, T., Ohashi, K., Nakazawa, H., Sugahara, H., Ago, H., et al. (2018). Hematopoietic cell transplantation for acute panmyelosis with myelofibrosis: a retrospective study in Japan.Biol Blood Marrow Transplant.
Shinohara, A., Oshima, K., Fuji, S., Umeda, K., Kako, S., Kurokawa, M., Tsukada, N., Kasai, M., Kondo, T., Hashii, Y., et al. (2019). Hematopoietic stem cell transplantation in solid organ recipients with emphasis on transplant complications: a nationwide retrospective survey on behalf of the JSHCT, transplant complications working group.Biol Blood Marrow Transplant.
Kaito, S., Nakajima, Y., Hara, K., Toya, T., Nishida, T., Uchida, N., Mukae, J., Fukuda, T., Ozawa, Y., Tanaka, M., et al. (2020). Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation.Blood Adv4, 1051-1061.
Kondo, E., Ikeda, T., Izutsu, K., Chihara, D., Shimizu-Koresawa, R., Fujii, N., Sakai, T., Kondo, T., Kubo, K., Kato, Y., et al. (2019). High dose chemotherapy with autologous stem cell transplantation in primary central nervous system lymphoma: Data from the Japan Society for Hematopoietic Cell Transplantation (JSHCT) registry.Biol Blood Marrow Transplant.
Kim, S.-W., Asakura, Y., Tajima, K., Iwai, T., Taji, H., Chou, T., Morishima, Y., Suzumiya, J., Sakamaki, H., Suzuki, R., et al. (2019). High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey.Int J Hematol.

Pages